Franklin Biotechnology Discovery Fund Class A (FBDIX)

Fund Assets	1.13B
Expense Ratio	1.026%
Min. Investment	$1,000
Turnover	37.62%
Dividend (ttm)	3.50
Dividend Yield	2.00%
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 22, 2025

Previous Close	171.73
YTD Return	3.61%
1-Year Return	21.43%
5-Year Return	49.41%
52-Week Low	159.04
52-Week High	213.76
Beta (5Y)	0.59
Holdings	118
Inception Date	Sep 15, 1997

About FBDIX

Franklin Biotechnology Discovery Fund Class A is a mutual fund that seeks capital appreciation by investing at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund focuses on companies involved in genomics, genetic engineering, gene therapy, pharmaceuticals, and related health care sectors. With a portfolio heavily weighted toward biotechnology and pharmaceutical industries, the fund aims to capitalize on innovations in cell and gene therapies, specialty drugs for rare diseases, and advanced treatment platforms. The fund maintains a diversified approach across approximately 80 biotechnology and pharmaceutical issuers, providing exposure to the evolving landscape of medical breakthroughs and therapeutic advancements. Managed by an experienced team since its inception, the fund distributes dividends annually and is designed for investors seeking long-term growth through participation in the biotechnology and life sciences sectors.

• Fund Family: Franklin Templeton
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Above Average
• Stock Exchange: Nasdaq
• Ticker Symbol: FBDIX
• Share Class: Class A
• Index: NASDAQ Biotechnology CR

Performance

FBDIX had a total return of 21.43% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.76%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
FRBRX	Class R6	0.67%
FTDZX	Advisor Class	0.76%
FBTDX	Class C	1.76%

Top 10 Holdings

36.65% of assets

Name	Symbol	Weight
Jazz Pharmaceuticals plc	JAZZ	5.06%
Amgen Inc.	AMGN	4.65%
argenx SE	ARGX	4.15%
Gilead Sciences, Inc.	GILD	4.11%
Vertex Pharmaceuticals Incorporated	VRTX	3.83%
Regeneron Pharmaceuticals, Inc.	REGN	3.74%
Revolution Medicines, Inc.	RVMD	3.13%
AstraZeneca PLC	AZN	2.72%
Ascendis Pharma A/S	ASND	2.68%
Amylyx Pharmaceuticals, Inc.	AMLX	2.57%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$17.9181	Dec 22, 2025
Dec 20, 2024	$11.7607	Dec 20, 2024
Dec 20, 2022	$0.1411	Dec 20, 2022
Dec 15, 2021	$17.6831	Dec 15, 2021
Dec 15, 2020	$10.3921	Dec 15, 2020
Dec 16, 2019	$14.1643	Dec 18, 2019

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error